JORGENSEN NATHAN D. (Chief Financial Officer) sold 5.8% of their position (7.67K shares) of VOYAGER THERAPEUTICS, INC. on the open market
Open‑market sale worth $36.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/7/2025ACC: 0001104659-25-097522
Officer· Chief Financial Officer
Since Feb 2026
-7.67K
Net shares
Net seller
$36.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.67K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.67K
Price / share
$4.78
Trade value
$36.64K
% of position
5.8%
10/3/2025
131.50K→123.83K
Total
Net shares
−7.67K
Net value
-$36.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/3/2025 | S · Sale | −7.67K | $4.78 | $36.64K | 5.8% | 131.50K | 123.83K |
| Total | −7.67K | -$36.64K | ||||||
Derivative Transactions0
No derivative transactions reported